UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 203

Sortiert nach

Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature

Oral oncology, 2012-11, Vol.48 (11), p.1085-1089

2012

Volltextzugriff (PDF)

A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma

Oral oncology, 2021-08, Vol.119, p.105366-105366, Article 105366

2021

Volltextzugriff (PDF)

Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma

Oral oncology, 2020-07, Vol.106, p.104690, Article 104690

2020

Volltextzugriff (PDF)

Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer

Oral oncology, 2019-08, Vol.95, p.120-126

2019

Volltextzugriff (PDF)

Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy

International journal of radiation oncology, biology, physics, 2008-11, Vol.72 (4), p.1110-1118

2008

Volltextzugriff (PDF)

Head and neck cancer

The Lancet (British edition), 2021-12, Vol.398 (10318), p.2289-2299

2021

Volltextzugriff (PDF)

Salivary Gland Tumors Treated With Adjuvant Intensity-Modulated Radiotherapy With or Without Concurrent Chemotherapy

International journal of radiation oncology, biology, physics, 2012, Vol.82 (1), p.308-314

2012

Volltextzugriff (PDF)

Relationship Between Radiation Treatment Time and Overall Survival After Induction Chemotherapy for Locally Advanced Head-and-Neck Carcinoma: A Subset Analysis of TAX 324

International journal of radiation oncology, biology, physics, 2011-12, Vol.81 (5), p.e813-e818

2011

Volltextzugriff (PDF)

Treatment of Oral Cavity Squamous Cell Carcinoma With Adjuvant or Definitive Intensity-Modulated Radiation Therapy

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (4), p.e215-e222

2011

Volltextzugriff (PDF)

Clinical trial data of Anti–PD-1/PD-L1 therapy for recurrent or metastatic nasopharyngeal Carcinoma: A review

Cancer treatment reviews, 2022-09, Vol.109, p.102428-102428, Article 102428

2022

Volltextzugriff (PDF)

Efficacy and Toxicity of Chemoradiotherapy Using Intensity-Modulated Radiotherapy for Unknown Primary of Head and Neck

International journal of radiation oncology, biology, physics, 2011-08, Vol.80 (5), p.1405-1411

2011

Volltextzugriff (PDF)

Clinical Practice Guidance for Radiotherapy Planning After Induction Chemotherapy in Locoregionally Advanced Head-and-Neck Cancer

International journal of radiation oncology, biology, physics, 2009-11, Vol.75 (3), p.725-733

2009

Volltextzugriff (PDF)

Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences

Oral oncology, 2016-10, Vol.61, p.19-26

2016

Volltextzugriff (PDF)

Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy

Cell, 2022-08, Vol.185 (16), p.2918-2935.e29

2022

Volltextzugriff (PDF)

Human papillomavirus–associated adenocarcinoma of the base of the tongue

Human pathology, 2013-08, Vol.44 (8), p.1516-1523

2013

Volltextzugriff (PDF)

A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

International journal of radiation oncology, biology, physics, 2021-01, Vol.109 (1), p.134-144

2021

Volltextzugriff (PDF)

Keynote 48: Is it really for everyone?

Oral oncology, 2020-06, Vol.105, p.104762-104762, Article 104762

2020

Volltextzugriff (PDF)

Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?

Cancer treatment reviews, 2023-09, Vol.119, p.102585-102585, Article 102585

2023

Volltextzugriff (PDF)

Reply to “Keynote 48: Is it really for everyone?”

Oral oncology, 2021-04, Vol.115, p.105108-105108, Article 105108

2021

Volltextzugriff (PDF)

Human papillomavirus–associated adenocarcinoma of the palatine tonsil—reply

Human pathology, 2014-04, Vol.45 (4), p.895-895

2014

Volltextzugriff (PDF)

Head and neck cancer: high-end technology is no guarantee of high-quality care – Authors' reply

The Lancet (British edition), 2022-06, Vol.399 (10341), p.2102-2102

2022

Volltextzugriff (PDF)

Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma

European journal of cancer (1990), 2019-05, Vol.113, p.1-9

2019

Volltextzugriff (PDF)

Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck

Oral oncology, 2020-06, Vol.105, p.104676-104676, Article 104676

2020

Volltextzugriff (PDF)

Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma

European journal of cancer (1990), 2019-12, Vol.123, p.138-145

2019

Volltextzugriff (PDF)

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19

Oral oncology, 2021-01, Vol.112, p.105087-105087, Article 105087

2021

Volltextzugriff (PDF)

1 – 25 von 203

Suche als RSS-Feed

Aktive Filter

PublikationsformBücher

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(193)
Mit Volltextzugriff
(202)

Publikationsform

Artikel
(201)
Berichte
(1)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(152)
Life Sciences & Biomedicine
(140)
Humans
(93)
Male
(55)
Female
(52)
Oncology
(49)
Biological And Medical Sciences
(39)
Middle Aged
(39)
Aged
(37)
Physical Sciences
(34)
Adult
(31)
Medical Sciences
(31)
Chemistry
(28)
Dentistry, Oral Surgery & Medicine
(26)
Biochemistry & Molecular Biology
(23)
Chemistry, Analytical
(21)
Hematology, Oncology And Palliative Medicine
(21)
Biochemical Research Methods
(19)
Aged, 80 And Over
(18)
Tumors
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Overcoming resistance to EGFR inhibitor in head and neck cancer: A review of the literature

A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma

Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma

Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer

Dose to Larynx Predicts for Swallowing Complications After Intensity-Modulated Radiotherapy

Head and neck cancer

Salivary Gland Tumors Treated With Adjuvant Intensity-Modulated Radiotherapy With or Without Concurrent Chemotherapy

Relationship Between Radiation Treatment Time and Overall Survival After Induction Chemotherapy for Locally Advanced Head-and-Neck Carcinoma: A Subset Analysis of TAX 324

Treatment of Oral Cavity Squamous Cell Carcinoma With Adjuvant or Definitive Intensity-Modulated Radiation Therapy

Clinical trial data of Anti–PD-1/PD-L1 therapy for recurrent or metastatic nasopharyngeal Carcinoma: A review

Efficacy and Toxicity of Chemoradiotherapy Using Intensity-Modulated Radiotherapy for Unknown Primary of Head and Neck

Clinical Practice Guidance for Radiotherapy Planning After Induction Chemotherapy in Locoregionally Advanced Head-and-Neck Cancer

Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences

Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy

Human papillomavirus–associated adenocarcinoma of the base of the tongue

A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Keynote 48: Is it really for everyone?

Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?

Reply to “Keynote 48: Is it really for everyone?”

Human papillomavirus–associated adenocarcinoma of the palatine tonsil—reply

Head and neck cancer: high-end technology is no guarantee of high-quality care – Authors' reply

Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma

Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck

Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma

Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19

Aktive Filter

Suchergebnisse filtern